Latest database descriptions

Describe the profile and the care for hypertensive patients treated with calcium channel blockers and their distribution according to the level of the cardio-vascular risk as defined by HAS (French National Authority for Health) 2005.
- Describe the distribution of the risk factors according to sub-groups of age.
- Describe the profile of hypertensive patients on calcium channel blockers according to blood pressure control.
- Describe the therapeutic strategy when the high blood pressure is not controlled.

Primary:
- Evaluate the frequency of anxiety and mood disturbances and the degree of sleeping disorders in patients monitored for PNP
Secondary:
- Describe the links between the components of the PNP and the existence of anxiety, mood disturbances and the degree of sleeping disorders,
- Describe the relations between the components of PNP, anxiety, sleeping disorders, mood disturbances on the one hand and the quality of life on the other hand,
- Describe the relation between the components of the PNP, the existence of anxiety and mood disturbances, the degree of sleep disorders on the one hand and the current drug care of patients on the other hand.

"Evaluate the distribution of the three clinical presentations of high blood pressure (family, metabolic or vascular hypertension) at general practitioners in 2005 in subjects treated or not treated for hypertension
- Evaluate the care of hypertensive subjects according to the various clinical presentations of high blood pressure (family, metabolic or vascular hypertension) diagnosed by general practitioners."

Describe the post-chirurgical drug treatment for pain after a surgical intervention, in target groups of patients having specific risks of developing complications during the use of certain classes of analgesics